Oral ixazomib maintenance following autologous stem cell transplantation (TOURMALINE-MM3): a double-blind, randomised, placebo-controlled phase 3 trial

TOURMALINE-MM3 study group

Research output: Contribution to journalArticlepeer-review

56 Citations (Scopus)

Fingerprint Dive into the research topics of 'Oral ixazomib maintenance following autologous stem cell transplantation (TOURMALINE-MM3): a double-blind, randomised, placebo-controlled phase 3 trial'. Together they form a unique fingerprint.

Medicine & Life Sciences